Chest X-ray Tomosynthesis for Lung Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether chest X-ray tomosynthesis, an advanced imaging technique, can effectively detect lung cancer compared to standard CT scans. It also aims to develop AI tools to identify lung cancer in these images. The trial seeks participants undergoing lung cancer screenings, those being evaluated for suspicious lung nodules, or individuals recently diagnosed with lung cancer. Participants will receive a chest tomosynthesis scan alongside their standard CT scan to compare the two methods. As a Phase 2 trial, this research measures the imaging method's effectiveness in an initial, smaller group, offering participants a chance to contribute to advancements in lung cancer detection.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that chest X-ray tomosynthesis is safe for lung cancer screening?
Research has shown that chest X-ray tomosynthesis is generally easy for patients to handle. This method uses less radiation than a standard CT scan, making it a safer option. Studies have found that although CT scans excel at detecting lung nodules, they expose patients to more radiation. In contrast, chest X-ray tomosynthesis offers reduced exposure. So far, no major reports of side effects have been directly linked to chest X-ray tomosynthesis in clinical settings, suggesting it is a safe choice for lung cancer screening.12345
Why are researchers excited about this trial?
Researchers are excited about chest X-ray tomosynthesis for lung cancer screening because it offers a potentially more detailed and accurate imaging method compared to standard chest X-rays and CT scans. Unlike traditional X-rays that produce a single flat image, tomosynthesis creates a 3D reconstruction of the chest, providing clearer views of lung structures. This could lead to earlier and more accurate detection of lung nodules, improving outcomes for patients by catching potential cancers sooner. Additionally, tomosynthesis generally involves lower radiation exposure than a CT scan, making it a safer option for regular screening.
What evidence suggests that chest tomosynthesis is effective for detecting lung cancer?
This trial will evaluate the effectiveness of chest X-ray tomosynthesis in participants who have recently undergone a routine clinical chest computed tomography scan for lung cancer screening or evaluation of nodules suspicious for lung cancer. Studies have shown that digital chest tomosynthesis surpasses standard chest X-rays in detecting small lung spots, known as nodules, identifying 91% of nodules that are 4 to 6 millimeters in size. Early detection of lung nodules is crucial for catching lung cancer sooner. Compared to CT scans, tomosynthesis uses less radiation, potentially making it a safer choice for regular check-ups. Although CT scans remain more effective for detecting lung cancer, tomosynthesis offers a promising option with better safety and fewer risks.12346
Who Is on the Research Team?
Albert Hsiao, MD PhD
Principal Investigator
UC San Diego, Department of Radiology
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Imaging
Participants undergo chest X-ray tomosynthesis and routine clinical chest CT scan for lung cancer screening or evaluation of suspicious nodules
Follow-up
Participants are monitored for diagnostic accuracy of chest tomosynthesis in identifying lung cancer and nodules
What Are the Treatments Tested in This Trial?
Interventions
- Chest X-ray Tomosynthesis
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Diego
Lead Sponsor
AIxSCAN, Inc.
Collaborator